Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Genistein and Equol's Effects on Cognitive Function Domains and Mood Measures in a Twelve-week Long Placebo-controlled, Double-blind Clinical Trial

NCT07742501 is registered in ClinicalTrials.gov with University of Reading as lead sponsor.

NCT NCT07742501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07742501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Genistein and Equol's Effects on Cognitive Function Domains and Mood Measures in a Twelve-week Long Placebo-controlled, Double-blind Clinical Trial
Lead sponsor
University of Reading
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2024
Completion date
October 14, 2025
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognition, mood